Literature DB >> 23897843

Additional value of prenatal genomic array testing in fetuses with isolated structural ultrasound abnormalities and a normal karyotype: a systematic review of the literature.

M C de Wit1, M I Srebniak, L C P Govaerts, D Van Opstal, R J H Galjaard, A T J I Go.   

Abstract

OBJECTIVE: To establish the prevalence of submicroscopic genetic copy number variants (CNVs) in fetuses with a structural ultrasound anomaly (restricted to one anatomical system) and a normal karyotype. The aim was to determine the diagnostic and prognostic value of genomic array testing in these pregnancies.
METHODS: Embase and PubMed databases were systematically searched for all relevant articles on prevalence of pathogenic submicroscopic CNVs in fetuses with ultrasound anomalies. Reported cases were sorted into groups according to anatomical site of the detected ultrasound anomaly. The prevalence of causative submicroscopic CNVs was calculated for each group.
RESULTS: Combined data of the reviewed studies (n = 18) indicated that fetuses with an ultrasound anomaly restricted to one anatomical system (n = 2220) had a 3.1-7.9% chance of carrying a causative submicroscopic CNV, depending on the anatomical system affected. This chance increased to 9.1% for fetuses with multiple ultrasound anomalies (n = 1139).
CONCLUSION: This review indicates that 3.1-7.9% of fetuses with a structural ultrasound anomaly restricted to one anatomical system and a normal karyotype will show a submicroscopic CNV, which explains its phenotype and provides information for fetal prognosis. Therefore, we conclude that microarray has considerable diagnostic and prognostic value in these pregnancies.
Copyright © 2013 ISUOG. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  isolated ultrasound abnormality; pathogenic submicroscopic CNV; prenatal array

Mesh:

Year:  2014        PMID: 23897843     DOI: 10.1002/uog.12575

Source DB:  PubMed          Journal:  Ultrasound Obstet Gynecol        ISSN: 0960-7692            Impact factor:   7.299


  25 in total

1.  Microarrays as a diagnostic tool in prenatal screening strategies: ethical reflection.

Authors:  Antina de Jong; Wybo J Dondorp; Merryn V E Macville; Christine E M de Die-Smulders; Jan M M van Lith; Guido M W R de Wert
Journal:  Hum Genet       Date:  2014-02       Impact factor: 4.132

2.  Array study in fetuses with nuchal translucency above the 95th percentile: a 4-year observational single-centre study.

Authors:  Edgar Coello-Cahuao; María Ángeles Sánchez-Durán; Inés Calero; María Teresa Higueras; Mayte Avilés García; Carlota Rodó; Nerea Maiz; Alberto Plaja Rustein; Neus Castells-Sarret; Carmen Mediano-Vizuete; Elena Carreras
Journal:  Arch Gynecol Obstet       Date:  2022-04-29       Impact factor: 2.344

3.  Prenatal Diagnosis Using Chromosomal Microarray Analysis in High-Risk Pregnancies.

Authors:  Ching-Hua Hsiao; Jia-Shing Chen; Yu-Ming Shiao; Yann-Jang Chen; Ching-Hsuan Chen; Woei-Chyn Chu; Yi-Cheng Wu
Journal:  J Clin Med       Date:  2022-06-23       Impact factor: 4.964

4.  Prenatal SNP array testing in 1000 fetuses with ultrasound anomalies: causative, unexpected and susceptibility CNVs.

Authors:  Malgorzata I Srebniak; Karin Em Diderich; Marieke Joosten; Lutgarde Cp Govaerts; Jeroen Knijnenburg; Femke At de Vries; Marjan Boter; Debora Lont; Maarten Fcm Knapen; Merel C de Wit; Attie Tji Go; Robert-Jan H Galjaard; Diane Van Opstal
Journal:  Eur J Hum Genet       Date:  2015-09-02       Impact factor: 4.246

Review 5.  Application of exome sequencing for prenatal diagnosis: a rapid scoping review.

Authors:  Misty Pratt; Chantelle Garritty; Micere Thuku; Leila Esmaeilisaraji; Candyce Hamel; Taila Hartley; Kathryn Millar; Becky Skidmore; Shelley Dougan; Christine M Armour
Journal:  Genet Med       Date:  2020-08-04       Impact factor: 8.822

6.  Whole-genome array CGH evaluation for replacing prenatal karyotyping in Hong Kong.

Authors:  Anita S Y Kan; Elizabeth T Lau; W F Tang; Sario S Y Chan; Simon C K Ding; Kelvin Y K Chan; C P Lee; Pui Wah Hui; Brian H Y Chung; K Y Leung; Teresa Ma; Wing C Leung; Mary H Y Tang
Journal:  PLoS One       Date:  2014-02-05       Impact factor: 3.240

7.  Array-based molecular karyotyping in fetuses with isolated brain malformations identifies disease-causing CNVs.

Authors:  Madita Schumann; Andrea Hofmann; Sophia K Krutzke; Alina C Hilger; Florian Marsch; Dietlinde Stienen; Ulrich Gembruch; Michael Ludwig; Waltraut M Merz; Heiko Reutter
Journal:  J Neurodev Disord       Date:  2016-04-15       Impact factor: 4.025

Review 8.  Chromosomal Microarrays in Prenatal Diagnosis: Time for a Change of Policy?

Authors:  Peter Miny; Friedel Wenzel; Sevgi Tercanli; Isabel Filges
Journal:  Microarrays (Basel)       Date:  2013-12-05

9.  Enlarged NT (≥3.5 mm) in the first trimester - not all chromosome aberrations can be detected by NIPT.

Authors:  Malgorzata I Srebniak; Merel C de Wit; Karin E M Diderich; Lutgarde C P Govaerts; Marieke Joosten; Maarten F C M Knapen; Marnix J Bos; Gerda A G Looye-Bruinsma; Mieke Koningen; Attie T J I Go; Robert Jan H Galjaard; Diane Van Opstal
Journal:  Mol Cytogenet       Date:  2016-09-07       Impact factor: 2.009

10.  Cell-free fetal DNA: the new tool in fetal medicine.

Authors:  T R Everett; L S Chitty
Journal:  Ultrasound Obstet Gynecol       Date:  2015-05       Impact factor: 7.299

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.